Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenazopyridine vs Lidocaine for Botox Analgesia in Overactive Bladder
NCT03755089Phase 4Unknown
- Sponsor
- Women & Infants Hospital
- Start
- Nov 2018
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of phenazopyridine in overactive bladder (OAB), sponsored by Women & Infants Hospital. Status: unknown.
02
Drugs
phenazopyridine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT03755089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03755089.